• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines 1,3,5-triazines Methylthio-s-triazines

Introduction to 4-(methylsulfanyl)-6-(trifluoromethyl)-1,3,5-triazin-2-amine (CAS No. 149525-97-3)

4-(methylsulfanyl)-6-(trifluoromethyl)-1,3,5-triazin-2-amine is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This triazine derivative belongs to a class of heterocyclic compounds that have garnered considerable attention due to their versatility in drug design and development. The molecular structure of this compound incorporates both methylsulfanyl and trifluoromethyl substituents, which contribute to its distinctive chemical behavior and potential biological activity.

The CAS number 149525-97-3 provides a unique identifier for this chemical entity, ensuring precise classification and reference in scientific literature and industrial applications. As a member of the triazine family, this compound exhibits reactivity patterns that are influenced by the presence of nitrogen atoms in its ring system. The trifluoromethyl group particularly enhances the lipophilicity and metabolic stability of the molecule, making it an attractive candidate for further exploration in medicinal chemistry.

In recent years, there has been growing interest in triazine derivatives as scaffolds for developing novel therapeutic agents. The combination of the methylsulfanyl and trifluoromethyl groups in this compound imparts specific electronic and steric properties that can be leveraged to modulate biological targets. For instance, studies have shown that such modifications can improve binding affinity to enzymes and receptors, thereby enhancing pharmacological efficacy.

One of the most compelling aspects of 4-(methylsulfanyl)-6-(trifluoromethyl)-1,3,5-triazin-2-amine is its potential application in the synthesis of agrochemicals and specialty chemicals. The triazine core is well-known for its role in herbicides and fungicides, where it acts as a key structural component. By introducing functional groups like methylsulfanyl and trifluoromethyl, researchers can fine-tune the properties of these compounds to achieve desired effects while minimizing environmental impact.

Recent advancements in computational chemistry have enabled more efficient virtual screening of candidate molecules like this one. Algorithms that predict molecular interactions can be used to identify potential drug candidates with high precision. The structural features of 4-(methylsulfanyl)-6-(trifluoromethyl)-1,3,5-triazin-2-amine, including its aromaticity and electron distribution, make it a promising candidate for further investigation using these methods.

The synthesis of this compound involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Techniques such as nucleophilic substitution and condensation reactions are commonly employed to construct the triazine ring system. The introduction of the methylsulfanyl group typically involves thiolation reactions, while the trifluoromethyl group is often incorporated via halogen-metal exchange or direct fluorination processes.

In terms of biological activity, preliminary studies on derivatives of this compound have revealed interesting properties relevant to therapeutic applications. For example, modifications at the 2-amino position can lead to compounds with enhanced binding affinity to certain protein targets. This has spurred research into developing novel inhibitors for diseases such as cancer and inflammatory disorders.

The role of fluorinated compounds in modern drug discovery cannot be overstated. The presence of fluorine atoms in molecules like this one can significantly alter their pharmacokinetic profiles, including bioavailability and metabolic stability. The trifluoromethyl group, in particular, is known for its ability to increase binding affinity through hydrophobic interactions and electronic effects.

As research continues to evolve, the applications of compounds like 4-(methylsulfanyl)-6-(trifluoromethyl)-1,3,5-triazin-2-amine are likely to expand beyond traditional pharmaceuticals into areas such as materials science and catalysis. The unique structural features of triazines make them valuable building blocks for designing complex molecules with tailored properties.

Collaborative efforts between academic institutions and pharmaceutical companies are essential for advancing the development of such compounds. By combining experimental data with computational modeling, researchers can accelerate the discovery process and bring new therapeutic agents to market more efficiently. The continued exploration of derivatives like this one holds promise for addressing unmet medical needs in the future.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)